May 2026 in “Southeast Asian Journal of Case Report and Review” In this study, individualized homoeopathic treatment with Silicea showed a marked reduction in depigmentation for a case of vitiligo, with a likely causal link suggested by evaluation criteria.
111 citations
,
August 1998 in “Journal of Investigative Dermatology” This study found that human epidermal keratinocytes express a functional μ-opiate receptor at both the mRNA and protein levels, potentially playing a role in skin physiology and pathology.
36 citations
,
November 2016 in “European journal of dermatology/EJD. European journal of dermatology” This review examines systemic drugs that can cause changes in hair color and emphasizes the importance of reporting these adverse events, but it does not include new clinical outcomes.
26 citations
,
August 2006 in “Journal of Clinical Pharmacy and Therapeutics” This study reported that enoxaparin may cause alopecia in patients treated for cerebral venous thrombosis, with hair growth resuming naturally after the treatment ended.
8 citations
,
May 2016 in “Indian Journal of Pharmacology” This case report describes an atypical postfinasteride syndrome in a patient treated with both dutasteride and finasteride for androgenic alopecia, highlighting its multisystem involvement and irreversible nature.
6 citations
,
January 2016 in “Journal of Clinical and Diagnostic Research” This case report describes a non-arteritic anterior ischemic optic neuropathy that resolved after discontinuing topical 5% minoxidil treatment.
6 citations
,
March 2014 in “Annals of Pharmacotherapy” This case report suggests that anidulafungin may be associated with hair loss, highlighting the need for physicians to monitor this potential adverse effect.
6 citations
,
October 2012 in “Pediatrics” This case report describes an 11-year-old girl who experienced hot flashes and menarche after taking a Serenoa repens supplement for telogen effluvium, suggesting a possible but uncertain link between the supplement and hormonal changes.
5 citations
,
July 2017 in “Skin appendage disorders” This case report describes a 35-year-old man who developed an atypical DRESS syndrome after taking topiramate for migraine prevention, which resolved with drug withdrawal and symptomatic treatment.
5 citations
,
March 2012 in “Veterinary dermatology” This case report describes a potential drug-induced localized scleroderma in a Persian cat following the application of a 'spot-on' treatment.
2 citations
,
June 2017 in “Psychiatry and clinical psychopharmacology” This case report describes the first known instance of hair loss linked to agomelatine, which resolved after the drug was discontinued.
1 citations
,
May 2025 in “Indian Dermatology Online Journal” This case report links sorafenib treatment in a 22-year-old man with relapsed acute myeloid leukemia to a rare instance of drug-induced pityriasis rubra pilaris-like eruption.
1 citations
,
January 2018 in “Eastern Journal Of Medicine” In this case report, a 9-year-old girl using topical minoxidil for alopecia experienced a 6-second asystole with syncope, suggesting careful cardiac monitoring may be needed for minoxidil users.
1 citations
,
January 2017 in “Journal of Clinical and Diagnostic Research” This case series reported three instances where alopecia linked to sodium valproate was reversed after discontinuing the drug.
August 2026 in “South Asian Journal of Health Sciences” In this case report, a 35-year-old man developed avascular necrosis after receiving intradermal corticosteroid injections for alopecia areata, marking the first documented instance of this side effect from such treatment.
July 2026 in “International Journal of Drug Delivery Technology” In this case report, a 14-year-old girl developed azathioprine-induced anagen effluvium, highlighting it as a rare but reversible side effect with prompt drug withdrawal leading to significant hair regrowth.
April 2026 in “BMC Oral Health” In this case report, a 45-year-old male developed recurrent, painful oral ulcers after starting finasteride for hair loss, with symptoms resolving after stopping the drug and returning upon rechallenge, suggesting a probable causal link.
January 2026 in “British Journal of Clinical Pharmacology” In this study, reports from individuals using Serenoa repens indicated a possible post-Serenoa syndrome characterized by persistent sexual and neuropsychiatric symptoms, with causality assessed as 'probable' in 54% of cases, highlighting an underrecognized safety concern that warrants further investigation.
December 2025 in “Journal of Integrated Standardized Homoeopathy” This case report describes the use of individualized homoeopathic treatment and dietary modifications to manage hypothyroidism in a 23-year-old woman, resulting in symptom improvement and normalized TSH levels after tapering off levothyroxine.
September 2025 in “Journal of Psychiatry Spectrum” This case report describes a rare instance of gynecomastia in a male patient undergoing mirtazapine treatment for depression, suggesting the drug as a probable cause after ruling out other factors.
June 2021 in “Psychiatria Danubina” The antidepressant escitalopram likely caused hair loss in a patient.
January 2014 in “IOSR journal of pharmacy” This case report identifies alopecia universalis as a probable adverse drug reaction to adalimumab in a patient with psoriasis and psoriatic arthritis.
June 2026 in “Indian Journal of Research in Homoeopathy” This case series evaluated the effects of individualised homoeopathic treatment on five patients with alopecia areata, finding clinical improvement and new hair growth in those treated with specific remedies like Phosphorus and Tuberculinum.
March 2026 in “International Journal of Reproduction Contraception Obstetrics and Gynecology” This case study suggests that homeopathic treatment with Pulsatilla may have contributed to improved menstrual regularity and ultrasonography results in a 22-year-old woman with PCOS.
March 2024 in “Homœopathic Links” This study evaluated two cases of individualised homoeopathic treatment for alopecia areata and found that Phosphorus treatment resulted in complete hair regrowth and symptom resolution over 18 months.
September 2022 in “PubMed” In this observational study, researchers reported beneficial results in treating an 18-year-old female with PCOS using individualized homeopathy and lifestyle modifications over one year, suggesting this approach as a complementary treatment option.
14 citations
,
March 2007 in “Pediatric pulmonology” This study found evidence suggesting that hypertrichosis may be an adverse effect of inhaled corticosteroids in children, although it does not always resolve after stopping treatment.
20 citations
,
August 2008 in “Journal of Medical Case Reports” This case report describes a probable hypersensitivity reaction to a single intravenous dose of ondansetron, highlighting the need for cautious use, especially in outpatient settings.
8 citations
,
June 2016 in “Journal of Pharmacy Practice” This case report suggests that lisinopril may cause alopecia, which resolved after the patient switched to losartan potassium.
5 citations
,
January 2021 in “Indian Journal of Pharmacology” This case study reports generalized keratosis pilaris as a rare cutaneous side effect of nilotinib in a 40-year-old woman with chronic myeloid leukemia, highlighting the need for awareness among physicians.